Treatment of mouse L 929 cells in cell culture with mouse interferon, prior to infection with reovirus type 3, decreased the amount of virus progeny formed. In infected, interferon-treated cells less reovirus specified double-stranded RNA (ds reoRNA) and single-stranded RNA accumulated than in infected control cells and the rate of ds reoRNA accumulation was inversely related to the concentration of interferon with which the cells were treated prior to infection. Since ds reoRNA can be conveniently assayed, this forms the basis of a fast and simple assay for interferons.
INTRODUCTION
Interferons are macromolecules produced in vertebrate cells after virus infection or certain other stimuli. They are excreted, react with other cells and make these inefficient in supporting the replication of a broad range of viruses (De Clercq & Merigan, I97O) . The identification of the steps in virus replication inhibited in interferon-treated cells is under study in many laboratories. Prerequisites of such studies are animal viruses whose life-cycle is known in some detail and whose replication is inhibited in interferon-treated cells.
Reovirus, an animal virus with a segmented double-stranded RNA (ds RNA) genome, fulfils these prerequisites (Gomatos & Tamm, I963 ; Watanabe, Millward & Graham, I968; Joklik, 197o) . The sensitivity to interferon of the multiplication of reovirus (type 2) in human amnion cells (Oie & Leh, I968) and of reovirus type 3 in mouse L cells (Gauntt, I972) was reported. In this communication we provide data indicating that the synthesis of reovirus (type 3) specified single-stranded RNA (ss reoRNA) and double-stranded RNA (ds reoRNA) is inhibited in interferon-treated mouse L cells and the extent of inhibition of ds reoRNA synthesis depends on the concentration of interferon to which the cells were exposed prior to infection. This serves as the basis of a convenient, fast assay for interferons. Several interferon assays have been described which are based on the inhibition of total RNA accumulation in cells treated with actinomycin D (to block RNA synthesis on a DNA template) and infected with a virus with a single-stranded RNA (ss RNA) genome (Allen & Giron, I97O; Miller et al. I97O; McWilliams et al. I97I ; A. S. Huang, personal communication (Eagle, I959) in an atmosphere of 5 ~ CO2 at 37 °C. The monolayers on 60 mm diameter Petri dishes (Falcon Plastics) were seeded with I to z x lO 6 cells and were used 48 to 7 z h later after having reached confluency. Reovirus (type 3, the DZARING strain, kindly provided by Dr A. Graham) (Graziadei & Lengyel, 1972) and EMC (encephalomyocarditis virus donated by Dr A. Burness) (Burness, i969) were propagated on L cells. VSV (vesicular stomatitis virus, the Indiana serotype kindly provided by Dr R. Goldsby) (Mudd & Summers, 197o) had been propagated earlier in chick embryo cells and was adapted to and propagated in L cells.
Plaque assays. Virus solution (o'5 ml) was added at 37 °C to L cell monolayers which had just reached confluency. The monolayer-containing plates were tilted every 15 min to distribute the virus solution evenly. Sixty minutes after infection with VSV or EMC and 9o min after infection with reovirus, the monolayers were overlaid with 4 ml of growth medium supplemented with IO ~ foetal calf serum and o'7 ~o Ionagar (Colab Laboratories, Chicago) and were further incubated. On the following day the EMC or VSV-infected monolayers were stained to make the plaques visible by pouring a second overlay identical with the first one except containing 0-6 mg/ml of neutral red. The reovirus-infected plates received their second 4 ml overlay (identical with the first one) 2 days after infection and a third 4 ml overlay containing neutral red 2 days later. Plaques were counted IZ to 24 h after staining.
Interferon preparation. Mouse interferon was produced as described earlier by infecting L cell monolayers with u.v.-irradiated Newcastle disease virus (Paucker et al. 197o) . Crude interferon (specific activity 4o ooo NIH reference units/mg protein) was obtained by dialysing the medium of cells treated with Newcastle disease virus against a pH 2 buffer (to inactivate the virus) and subsequently against a neutral buffer. Partially purified interferon (specific activity 3 x IO 7 NIH reference units/mg protein) was prepared by chromatography on sulphoethyl Sephadex followed by disc electrophoresis on polyacrylamide gel (Paucker & Stan~ek, 1972) . The eluates from the gel slices containing most of the interferon were pooled. Bovine plasma albumin (o'5 ~, w/v) was added to stabilize the interferon activity (Stan~ek & Paucker, I97o) .
Interferon treatment ofmonolayers. Interferon (in the amounts specified in the legends to the figures) was added in 4 ml growth medium to monolayers of L cells on 6o mm plates at about 48 h after the plates had been seeded. At this time the layers were almost confluent (approximately 5 to 7 × 1 °6 cells/plate). After an 18 h incubation at 37 °C the monolayers were washed twice with warm growth medium and used immediately for interferon assays.
Interferon assays
Single-cycle yield reduction. Interferon treated and control monolayers were infected with virus in o'5 ml growth medium at an input multiplicity of o.z p.f.u./cell and incubated at 37 °C. Sixty minutes later in the case of VSV and 9o min later in that of reovirus the monolayers were washed with growth medium to remove the unadsorbed virus, and supplemented with 4 ml of growth medium. The monolayers were further incubated and were frozen IO h after infection in the case of VSV and 18 h in that of reovirus. The cells in the monolayers were lysed by freezing and thawing them three times and the lysates were centrifuged at I5OO g for IO min. The amount of infected virus in the supernatant fluid was determined in the plaque assay.
Plaque reduction. Interferon-treated and control monolayers were infected with virus solutions to result in 5o to xoo plaques of VSV (or EMC) or Ioo to 2oo of reovirus/control monolayer. The conditions of the assay were as described for the case of plaque assays. One unit of interferon (throughout this paper) is that amount with which a monolayer has to be treated to reduce the VSV plaque number by 5o ~ compared to that in a control plate (see Fig. I ). One of our units corresponds to about I2 NIH mouse reference interferon units.
Inhibition of ds reoRNA accumulation. Interferon-treated and control monolayers were infected with reovirus in o'5 ml growth medium at an input multiplicity of Io p.f.u./cell and incubated at 37 °C with occasional tilting to distribute the virus evenly for 9o rain. Unadsorbed virus was removed by washing the monolayers with growth medium, 3 ml of growth medium supplemented with o'5 #g of actinomycin D/ml was added to each plate and the incubation was continued. Eight hours later the medium was removed, I-5 ml of growth medium containing 2 #Ci/ml of [5-3H]-uridine (24.6 Ci/m-mol) and o. 5 #g/ml actinomycin D were added to each plate, and the incubation was continued. Three hours later the plates were washed 3 times in cold buffer I (Io mM-tris-C1 (pH 8-o) containing I4o mM-NaC1 and I mM-ethylenediaminetetra-acetate) and if not extracted immediately then frozen at -2o °C. For extraction the plates were supplemented with 2 ml of buffer I and 2 ml of 85 ~o phenol in buffer I. The suspension of detached cells was mechanically agitated for I5 rain at room temperature and then centrifuged at 3ooo g for Io rain. The aqueous layer was removed, washed 3 times with ether to remove phenol and incubated with shaking at 37 °C for 3o min to remove the ether. Double-stranded reoRNA was assayed in the aqueous layer by incubating duplicate samples with Io/~g/ml ribonuclease (protease-free bovine pancreatic ribonuclease A (E.C. 2.7-7. I6) from the Sigma Chemical Company, St Louis) in 2o mM-tris-C1 buffer (pH 7"4) containing 3oo mM-NaC1 at 37 °C for 2o rain. The undigested portion of the RNA (ds reoRNA) was precipitated by adding IOO #g/ml of bovine serum albumin and 5 ~ trichloroacetic acid. The precipitate was filtered through a nitrocellulose filter and the radioactivity in this was assayed in a toluene based scintillator in a liquid scintillation counter. Uninfected controls were included in each assay. The amount of radioactivity in these was not affected significantly by interferon. For each set of assays the following standards were tested: 2"5, 5, 7"5, I2"5 and 25 units of interferon. The results were plotted as in Fig. 4 . The plot of the log of interferon units versus log of the percentage ds reoRNA accumulated gave a straight line between 5 and 5o units of interferon (IOO ~ is the amount of ds reoRNA accumulated in infected cells not treated with interferon). The potency of the unknown interferon sample was established by interpolation in the straight line region of the plot.
RESULTS

Inhibition of VSV, EMC virus and reovirus replication by interferon
The potency of the interferon preparation used in our studies was determined in the plaque reduction assay with VSV. The amount of interferon causing a 5o ~ decrease in the plaque number is defined as one unit (Fig. I) . The interferon sensitivity of VSV (having as its genome single-stranded RNA complementary in sequence to mRNA) (Baltimore, Huang & Starnpfer, I97o) differed only slightly, if at all, from that of EMC virus (having as its genome single-stranded RNA serving as mRNA) (Smith, Marcker & Mathews, I97o) (Fig. I) .
The interferon sensitivity of VSV was compared with that of reovirus (having as its genome segmented double-stranded RNA) in the single cycle yield reduction assay. About twice as much interferon was needed to reduce the yield of reovirus by 50 ~ as for VSV (Fig. 2) . We could not use the plaque reduction assay in this comparison involving reovirus since our reovirus stock gave small plaques.
Interferon assay based on the inhibition of ds reoRNA accumulation
Reovirus specific double-stranded RNA can be conveniently determined in a cell extract since (a) in uninfected cells the large majority of RNA is apparently single-stranded (Stern & Friedman, I970 and (b) single-stranded RNA can be selectively hydrolysed with pancreatic ribonuclease A leaving double-stranded RNA intact (Geiduschek, Moohr & Weiss, 1962) . We tested the effect of interferon treatment on ds reoRNA accumulation for two reasons: (0 to find out if the accumulation is inhibited in interferon-treated cells in which reovirus mukiplication is inhibited and, if so, (2) to see if the inhibition could serve as a basis for an interferon assay. Synthesis of ds reoRNA at 37 °C was reported to start at about 6 h after infection and to proceed for about 14 h (Shatkin, 1969) . We followed the kinetics of ds reoRNA synthesis in control cells and in cells treated with interferon. The curves in Fig. 3 reveal that (a) the amount of accumulated ds reoRNA increases with the input multiplicity; and (b) interferon inhibits ds reoRNA accumulation and the extent of inhibition increases with the amount of interferon. The effect of treating L cells with various concentrations of interferon prior to infection with reovirus on the amount of ds reoRNA accumulated between 7 and I I h after infection is shown in Fig. 4 -It can be seen that the inhibition of ds reoRNA accumulation can serve as the basis of an assay for interferon. This assay has been in use in our laboratory for almost I year. The sensitivity of it in its present form is one-sixth of that of the plaque reduction assay with VSV; i.e. in our conditions about 6 (VSV plaque reduction) units of interferon caused 5o ~ inhibition of ds reoRNA accumulation. However, both the speed and the reproducibility of the assay are superior. It can be IP: 54.70.40.11
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In this assay partially purified interferon was used; in all the others, crude interferon.
completed in I'5 days. Its reproducibility and precision are shown in Table I . For this table five separate assays of the same interferon preparation were performed on different days. The standard deviation in this series was less than 2o ~. The age of the cell culture affects the sensitivity of the assay (see also McLaren, I97o). We performed the assay routinely with cells which had just reached confluency at the time when we started the interferon treatment. The sensitivity of the assay is 5o ~o higher when performed on cells 2 days after they have reached confluency. The assay can be run without actinomycin D. However, in this case there is more of host specific, ribonuclease-resistant labelled RNA present (as determined in uninfected cells).
To verify that the ds RNA determined in our assay is indeed reovirus-specific, a sample of the ribonuclease A-resistant material extracted from virus-infected cells not treated with interferon was analysed by polyacrylamide gel electrophoresis. The pattern obtained was indistinguishable from that obtained by analysing the ds RNA extracted from purified reovirus (see, for example, Shatkin, I969).
DISCUSSION
Most of the interferon assays in use are based on the inhibition of a manifestation of virus infection. These include reduction of plaque number, plaque size, virus yield and cytopathic effect (Finter, I966) . Recently a new type of assay was described which is based on the inhibition of virus RNA synthesis. This is usually performed in cells treated with actinomycin D to block host RNA synthesis (i.e. transcription of DNA) and infected with a RNA virus with a single-stranded RNA genome, whose replication is only slightly (if at all) sensitive to actinomycin D (Allen & Giron, I97O; Miller et al. 197o; McWilliams et al. I970-An assay based on ds reoRNA synthesis has the following merits. A well-defined virus component, ds RNA is determined in it and it could be performed without treating cells with actinomycin D, i.e. under more physiological conditions. The assay described in this communication was found to be relatively fast, convenient, and gave reproducible results.
In the course of our studies we found that the accumulation of ds reoRNA was more inhibited by interferon treatment than that of ss reoRNA. Furthermore, no obvious difference was detected either among the inhibition of the accumulation of the various ss reoRNA species or among that of the various ds reoRNA segments (data not shown).
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